Manufacturer record
BON-HEUR Pharmaceuticals: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by BON-HEUR Pharmaceuticals (Uttarakhand) were declared Not of Standard Quality between January 2026 and September 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: BHT-25021604, Gabapentin Tablets IP 300mg (exp Jan 2027). DTL, Jodhpur (state lab) found it not of standard quality: The sample does not conform to the I.P. with respect to Dissolution. Listed in the September 2026 alert.
Records by type
2 records linked to BON-HEUR Pharmaceuticals in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Gabapentin Tablets IP 300mg | Batch BHT-25021604Mfg Feb 2025 · Exp Jan 2027 | The sample does not conform to the I.P. with respect to Dissolution.Dissolution | DTL, JodhpurState lab | Sep 2026 |
| Rabeprazole Sodium Gastro-resistant and Domperidone Prolonged-release Capsules | Batch BHC-25070175Mfg Jul 2025 · Exp Dec 2026 | The sample does not conform to the claim with respect to Assay of Rabeprazole Sodium.Assay | DTL JaipurState lab | Jan 2026 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.